Found 5 results

Name Type of Offering Accepted Date
Poseida Therapeutics, Inc. See All Filings
D 2019-04-22 14:51:42
Amount To Be Raised $150,000,000
Associated Brokers / Dealers N/A
CIK Number 0001661460
Filed Document 0001661460-19-000003
Exclusions or Exemptions 506b
Accepted Date 2019-04-22 14:51:42
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
Poseida Therapeutics, Inc. See All Filings
D 2015-12-23
Amount To Be Raised $36,033,230
Associated Brokers / Dealers N/A
CIK Number 0001661460
Filed Document 0001661460-15-000001
Exclusions or Exemptions 506b
Accepted Date 2015-12-23
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
Poseida Therapeutics, Inc. See All Filings
D 2017-08-02 21:50:43
Amount To Be Raised $15,000,000
Associated Brokers / Dealers N/A
CIK Number 0001661460
Filed Document 0001661460-17-000001
Exclusions or Exemptions 506b
Accepted Date 2017-08-02 21:50:43
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
Poseida Therapeutics, Inc. See All Filings
D 2018-04-03 15:24:51
Amount To Be Raised $30,499,990
Associated Brokers / Dealers N/A
CIK Number 0001661460
Filed Document 0001661460-18-000001
Exclusions or Exemptions 506b
Accepted Date 2018-04-03 15:24:51
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
Poseida Therapeutics, Inc. See All Filings
D 2023-08-11 16:48:17
Amount To Be Raised $24,999,999
Associated Brokers / Dealers N/A
CIK Number 0001661460
Filed Document 0001661460-23-000003
Exclusions or Exemptions 506b
Accepted Date 2023-08-11 16:48:17
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity